TickerFacts.

Company research / BHST

Bioharvest Sciences Inc. (BHST)

Build a valuation ↗↓ Download CSV

SEC name BIOHARVEST SCIENCES INC. · CIK 0001723464 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Bioharvest Sciences Inc. reported revenue of $34.51M. Revenue grew 37.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

59.3%
Gross margin (computed)
-16.2%
Operating margin
-32.3%
Net margin
-43.8%
Return on year-end equity
37.0%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-31
Revenue$34.51M$25.19M$12.67M
Cost of Revenue$14.03M$11.25M$7.04M
Gross Profit (computed)$20.48M$13.94M$5.63M
Operating Income-$5.58M-$6.99M-$9.97M
Depreciation & Amortization$1.62M$1.25M$840.0K
EBITDA-$3.95M-$5.74M-$9.13M
Net Income-$11.13M-$12.91M-$12.56M
Shareholders' Equity$25.45M$1.33M-$14.85M
Cash & Equivalents$23.02M$2.39M$5.36M
Operating Cash Flow-$7.23M-$6.68M-$8.52M
Capital Expenditures$2.35M$2.83M$1.47M
Free Cash Flow-$9.58M-$9.52M-$10.00M
EPS (Basic)-$0.60-$0.80-$0.93

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView